1. Home
  2. UCTT vs PGEN Comparison

UCTT vs PGEN Comparison

Compare UCTT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultra Clean Holdings Inc.

UCTT

Ultra Clean Holdings Inc.

N/A

Current Price

$78.76

Market Cap

3.3B

Sector

Technology

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$8.25

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UCTT
PGEN
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
UCTT
PGEN
Price
$78.76
$8.25
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
★ $137.00
$13.65
AVG Volume (30 Days)
667.6K
★ 3.6M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.03
Revenue
★ $1,734,500,000.00
$230,981,000.00
Revenue This Year
$32.58
$2,365.68
Revenue Next Year
$42.02
$85.75
P/E Ratio
★ N/A
$271.00
Revenue Growth
N/A
★ N/A
52 Week Low
$21.49
$2.99
52 Week High
$144.22
$8.27

Technical Indicators

Market Signals
Indicator
UCTT
PGEN
Relative Strength Index (RSI) 57.06 72.48
Support Level $70.18 $6.41
Resistance Level $84.43 N/A
Average True Range (ATR) 3.11 0.45
MACD 1.65 0.09
Stochastic Oscillator 86.74 84.01

Price Performance

Historical Comparison
UCTT
PGEN

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments: Products and Services. Its principal markets are the Americas, Asia Pacific, and EMEA.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: